Pomerantz LLP

Please review this complaint. Click to Contact Us about joining this ACTION >>

Questions? Ask Us

Learn More Contact Us

Pomerantz survived defendants’ motion to dismiss this litigation against the high-profile pharmaceutical company for charges related to Mylan's alleged systemic practice of over-charging Medicaid for its Epi-pens.

Read about the case here.